Submit Your Alzheimer's Disease Research
Join leading neuroscientists and pathophysiology researchers advancing our understanding of Alzheimer's disease mechanisms, biomarkers, and therapeutic targets
Two Convenient Submission Methods
We offer two streamlined pathways for submitting your Alzheimer's disease research. Choose the method that best fits your workflow and manuscript complexity.
ManuscriptZone Portal
Our comprehensive manuscript management system designed for complex submissions with multiple authors, extensive supplementary materials, and ongoing revisions.
- Auto-save functionality protects your work
- Real-time submission status tracking
- Direct communication with reviewers
- Guided workflow for complex manuscripts
- Secure file upload for large datasets
- Revision management tools
Best for: Original research articles, systematic reviews, multi-center studies, manuscripts with extensive supplementary data
Submit via ManuscriptZoneQuick Submission Form
A streamlined, single-page submission process for straightforward manuscripts. Complete your submission in under 15 minutes without creating an account.
- No account registration required
- Simple one-page form
- Fast submission process
- Ideal for shorter manuscripts
- Immediate confirmation email
- Direct editorial team contact
Best for: Short communications, case reports, letters to the editor, commentaries, preliminary findings
Use Quick Submission FormAlzheimer's Disease Research We Publish
We welcome rigorous pathophysiology research that advances our understanding of Alzheimer's disease mechanisms, from molecular pathways to translational applications. Our expert reviewers specialize in neurodegenerative disease research and provide constructive feedback to strengthen your work.
Original Research Articles
Comprehensive studies on amyloid-beta pathology, tau protein mechanisms, neuroinflammation, synaptic dysfunction, or genetic risk factors
Biomarker Discovery Studies
Novel biomarker identification using CSF analysis, neuroimaging, blood-based markers, or multi-omics approaches for early detection and disease monitoring
Disease Mechanism Studies
Investigations of molecular pathways, protein aggregation, mitochondrial dysfunction, oxidative stress, or cellular signaling in Alzheimer's pathogenesis
Animal Model Research
Studies using transgenic mice, cellular models, or other experimental systems to investigate disease mechanisms and therapeutic targets (ARRIVE guidelines required)
Systematic Reviews & Meta-Analyses
Comprehensive syntheses of pathophysiological mechanisms, biomarker studies, or preclinical research findings (PRISMA guidelines required)
Methods & Protocols
Novel experimental techniques, assay development, imaging protocols, or analytical methods for Alzheimer's disease research
Short Communications
Preliminary findings, novel observations, or timely reports of significant mechanistic discoveries requiring rapid dissemination
Perspective & Commentary
Expert opinions on emerging concepts in Alzheimer's pathophysiology, controversial mechanisms, or future research directions
Pre-Submission Checklist
Ensure your manuscript meets our requirements before submission. Complete manuscripts receive faster editorial screening and enter peer review more quickly.
Transparent Peer Review Timeline
We believe in transparency. Here's exactly what happens after you submit your Alzheimer's disease research, with realistic timelines based on our actual performance data.
Submission Received
Your manuscript enters our system and you receive immediate confirmation. Our editorial team begins initial screening for scope, completeness, and adherence to guidelines.
Day 0Editorial Screening
An editor with expertise in Alzheimer's pathophysiology reviews your manuscript for scientific quality, novelty, and fit with journal scope. Plagiarism check performed using iThenticate.
Days 1-3Peer Review Assignment
We invite 2-3 expert reviewers specializing in your research area (amyloid pathology, tau mechanisms, neuroinflammation, etc.). Reviewers are selected based on publication record and expertise match.
Days 4-7Expert Review
Reviewers evaluate scientific rigor, methodology, data interpretation, and significance to Alzheimer's research. They provide detailed feedback to strengthen your manuscript.
Days 8-28Editorial Decision
The handling editor synthesizes reviewer feedback and makes a decision: Accept, Minor Revisions, Major Revisions, or Reject. You receive detailed reviewer comments and editorial guidance.
Day 28Revision & Re-review
If revisions are requested, you submit your revised manuscript with a point-by-point response. Reviewers evaluate your changes and provide final recommendations.
Days 29-42Acceptance & Production
Upon acceptance, your manuscript enters production for copyediting, typesetting, and final proofing. You review and approve the final proof before publication.
Days 43-53Online Publication
Your research is published online with immediate Open Access. Indexed in and Google Scholar within 48 hours. DOI assigned and article metrics tracking begins.
Day 60Average Timeline: 60 Days from Submission to Publication
This timeline represents our median performance across all manuscript types. Short communications may be published faster (35-40 days), while complex systematic reviews may take longer (75-90 days). We prioritize quality over speed, but we respect your time and work efficiently at every stage.
Why Alzheimer's Researchers Choose Us
We understand the competitive landscape of Alzheimer's disease research. Here's what sets us apart from larger publishers and why leading pathophysiology researchers trust us with their work.
Submission Requirements for Alzheimer's Research
Manuscript Structure
Your manuscript should follow standard scientific format with sections appropriate to your study type:
- Title: Concise and descriptive (maximum 150 characters)
- Abstract: Structured abstract (Background, Methods, Results, Conclusions) - 250-300 words
- Keywords: 5-8 keywords relevant to Alzheimer's pathophysiology
- Introduction: Clear rationale, research gap, and study objectives
- Methods: Detailed protocols enabling replication (animal models, cell lines, assays, statistical analyses)
- Results: Clear presentation with appropriate figures and tables
- Discussion: Interpretation in context of Alzheimer's pathophysiology literature
- References: Vancouver or APA style, minimum 30 references for original research
Ethical Requirements
All research involving human subjects or animal models must meet ethical standards:
- Human Studies: IRB approval required, informed consent documented, patient privacy protected
- Animal Studies: IACUC approval required, ARRIVE guidelines followed, humane treatment documented
- Cell Lines: Authentication and mycoplasma testing documented
- Data Sharing: Raw data deposited in appropriate repositories (e.g., Gene Expression Omnibus for genomics)
Figure and Table Guidelines
- Format: TIFF or EPS for figures, editable format for tables
- Resolution: Minimum 300 DPI for print quality
- Labels: Clear axis labels, scale bars for microscopy images, statistical significance indicated
- Legends: Comprehensive figure legends enabling standalone interpretation
- Color: Colorblind-friendly palettes recommended
Frequently Asked Questions
What makes a strong Alzheimer's disease manuscript?
Strong manuscripts demonstrate: (1) Clear mechanistic insights into disease pathophysiology, (2) Rigorous experimental design with appropriate controls, (3) Robust statistical analyses, (4) Transparent reporting of methods and data, (5) Thoughtful discussion of limitations, and (6) Significance to the Alzheimer's research community. We value scientific rigor over novelty alone.
Do you accept negative results?
Yes. Well-designed studies with negative or unexpected results are valuable to the Alzheimer's research community. They prevent duplication of effort and refine our understanding of disease mechanisms. We evaluate manuscripts based on scientific rigor, not outcome direction.
What is your policy on preprints?
We encourage preprint posting (bioRxiv, medRxiv) and accept manuscripts previously posted as preprints. Preprint posting does not affect editorial consideration. Please disclose preprint posting in your cover letter.
How do you handle revisions?
Most manuscripts require revisions. We provide detailed reviewer feedback and editorial guidance. You'll have 60 days to submit revisions (extensions available upon request). Include a point-by-point response addressing each reviewer comment. Revised manuscripts typically receive faster re-review (14 days average).
What are your article processing charges (APCs)?
APC information is available on our journal homepage. We offer waivers for authors from low-income countries and discounts for unfunded research. Financial constraints should never prevent publication of quality research - contact us to discuss options.
Can I suggest reviewers?
Yes. You may suggest up to 3 potential reviewers with relevant expertise. Please provide their names, affiliations, and email addresses. You may also request exclusion of specific reviewers (with justification). Final reviewer selection remains with the editor.
Ready to Submit Your Alzheimer's Research?
Join the community of neuroscientists advancing our understanding of Alzheimer's disease pathophysiology. Our expert reviewers and editorial team are ready to help you share your discoveries with the world.
Need assistance with your submission? Our team is here to help: [email protected]
Begin Your Submission
